±z¥²¶· µn°O ¦b±z¯à±i¶K¦b§Ú̪º½×¾Â©Î¨Ï¥Î§ÚÌ¥ý¶iªº¥\¯à¤§«e¡C±H¦s¾¹²{¦b! ¨ä¦Û¥Ñ©M§Ö³t!
¤w¸gµn°O? µn¿ý²{¦b¤U±¡C
¤w¸gµn°O©M§Ñ°O¤F±zªº¤f¥O? ÂIÀ»¦p¤U¦¬¦^¥¦¡C
«n¨Æ¦b¬ì¾Ç«D±`¤£¬OÀò±o·s«Ø±¡ªp¦Ü©óµo²{·s«Ø«äºû¤è¦¡¥LÌ¡C~William ³ÒÛ´µ¡PBragg
¦b¤À¤l±^¦ì§K¬Ì¾Ç®a®x±z±N¬d§ä¸ê°T¡B¨óij¡Bbioinformatics, ©M³sµ²:
§K¬Ì¾Ç: Bioinformatics ¦b§K¬Ì¾Ç
CpG oligodeoxynucleotide ¨ë¿E¤Ï¶Ý¤¤©Êªº¥Í²£²ÓM½è... Ãö«Y¤F±ø´Ú
CpG oligodeoxynucleotide ¨ë¿E¤Ï¶Ý¤¤©Ê²ÓM½è§ÜÅ骺¥Í²£¦bANCA ³QÃöÁpªº¯ßºÞª¢¡C
BMC Immunol ¡C14;9(1):34 7¤ë2008 ¤é
§@ªÌ: Hurtado PR, Jeffs L, Nitschke J, Patel M, Sarvestani G, Cassidy J, Hissaria P, Gillis D, Peh ¥[¦{
ºKn: I´º: Wegener ªº¦×ªÞ¸~¯f©M·LÆ[Polyangiitis ¬O¥¼ª¾ªºì¦]½×«Â¯Ù¥Í©Rªº¨t²ÎÃa¦ºªºvasculitides ¡C¬y³qªº§ÜÅé¥~Æ[¹ï¶Ý¤¤©Ê²ÓM½è§Üì(ANCA) ±j¯P¦P¯e¯fªºµo®iÁpô¦b¤@°_¡C¤@Ó³sµ²¦b¶Ç¬V©M¯e¯f¤§¶¡ªø´Á³QÃhºÃ, ¨Ã¥BANCA §ÜÅé¥~Æ[³Q³ø§i¤F¸òÀH²Óµß©M¯f¬r¶Ç¬V¡C¬y³qB ¹q¦Àªº¨úºÉ¥Hmonoclonal §ÜÅéÀøªk¥i¯à¾ÉP¼e®¤, ¨Ã¥B³oÆ[¹î«ØÄ³¤@ÓP¯f©Ê¨¤¦â¬°B ¹q¦À¦b³oºØ¯e¯f¡C·í²ÓµßDNA ª¾¹D¾ÉPB ¹q¦ÀÂX´²©M§ÜÅé¥Í²£³q¹LTLR-9 ¨ë¿E, §Ú̱´¯Á¤F¨Ì·Ó³Q¬d§äunmethylated CpG oligodeoxynucleotide ªº¥i¯à©Ê, ¦b²Óµß¨Ã¥B¯f¬rDNA, ¤]³\¥R·í¤@Ó¨¤¦â¦b¨ë¿Eªº¬y³qªºautoreactive B ¹q¦À¸Ì¥Í²£ANCA ¦b±wªÌ»P¯ßºÞª¢¡Cµ²ªG: §ÚÌÃÒ¹ê¤Funmethylated CpG oligonucleotide ¬O§ÜÅé¥Í²£¤@¥ó¦³¤O¨ë¿E«~¥ÑPBMC ¦b¸ÕºÞ¤º¡CPBMC ªº¨ë¿E¥HCpG oligonucleutides ¾ÉP¬Û¦üªº¬Û·í¼Æ¶qªº¥Í²£IgG ¦bANCA+ ±wªÌ©M¥¿±`±±¨î¡C¤£ºÞ³oÓPR3 ANCA+ ±wªÌºî¦X¤FÅãµÛª÷ÃB¤WIgG ANCA ¤ñ¥¿±`±±¨î¡C¦bMPO ANCA+ ±wªÌ, ¦³¤ñ±±¨î, µM¦Ó, ®tÃB¨S¦³¨ì¹F·N¸q¤@ӶɦV¨Ï±wªÌ¥Í²£ª÷ÃB¤WANCA ¡C¦¹¥~, §Ú̯àÀË´ú¬y³qªºMPO ©ö¤ÏÀ³ªºB ¹q¦À¥ÑELISpot ÀËÅç±q2 ¦WMPO+ ANCA ¯ßºÞª¢±wªÌ¥~³ò¦å²G¡C¤@°_, ³oªí©ú, ¬y³qªº¤Ï¶Ý¤¤©Êautoreactive B ¹q¦À¬O¦s¦b¦bANCA+ ¯ßºÞª¢±wªÌ, ¨Ã¥B¥L̬O¯à¥Í²£§ÜÅé¥H¦^À³CpG ¨ë¿E¡Cªþµù, CpG ¨Ã¥B¾ÉP¬ÛÃöªº¦Û¨§ÜÅ骺¥Í²£¦b¦³¨ä¥¦Ãþ«¬¯f¤H¦Û°Ê§K¬Ìªº¯e¯f¡Cµ²½×: ¬y³qªºANCA autoreactive B ¹q¦À¬O¦s¦b¦b±wªÌ»PANCA+ ¯ßºÞª¢¡CANCA ªº¥Í²£±q³o¨Ç¹q¦À¥H¦^À³unmethylated CpG ¨ë¿E±a»â§ÚÌ´£Ä³, ³o¨Ç¹q¦Àªº¨ë¿E¥Ñimmunostimulatory DNA ¶¶§ÇÄ´¦pCpG oligodeoxynucleotide ¦b¶Ç¬V´Á¶¡¤]³\´£¨Ñ¤@Ó³sµ²¦b¶Ç¬V©MANCA ³QÃöÁpªº¯ßºÞª¢¤§¶¡¡C³oºØ²{¶H¤]³\¨Ã¥B¾A¥Î©ó¨ä¥¦§ÜÅéºW±Ûªº¦Û°Ê§K¬Ìªº¯e¯f¡C
PMID: 18625057 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
¥ÌÅS¿}·P¨ü¾¹©x§x¹ÒTrichuris muris excretory/secretory ³J¥Õ½è¦ý¤£¬O«n¬°¨¾Å@§K¬Ì¡C
§K¬Ì¾Ç¡C27 6¤ë2008 ¤é;
§@ªÌ: Deschoolmeester ¾÷¾¹»y¨¥, Martinez-Pomares L, Gordon S, KJ
Trichuris muris ¬O¤Hªº¹¹D½uÂαH¥Í¥Íª«Trichuris trichiura ªº¤@Ó¦ÛµM·Æ¹«³]p¨Ã¥B¥¦¬O·½»·¬yªøªºT »²§U¤uÃþ«¬³Q2 ±±¨îªº§K¬Ì¤ÏÀ³¥²»Ý¬°Ä¯Âζ}°£¡C¥¨¾½²ÓM²Öp¦b·Æ¹«ªº¤j¸z¦b¶Ç¬V´Á¶¡¨Ã¥B³o¨Ç¹q¦Àª¾¹Dªí¹F¥ÌÅS¿}·P¨ü¾¹©x(¥ý¥Í), ¤]³\§@¬°¼Ò¦¡ÃѧO·P¨ü¾¹©x¡C¸ê®Æ²Ä¤@¦¸³o¸Ì¦s¦b¤FT. muris excretory/secretory ²£«~ªºÅã¥Ü(E/S) ¾ÉP°©ÀY°©Åè³Q¬£¥Íªº¥¨¾½²ÓM(BMDM) ¥Í²£´Xcytokines ©M¦³¥ý¥Í§ô¿£ªº¬¡°Ê¡C¨Ï¥Î´À¥N³Q¿E¬¡ªºBMDM ±q·Æ¹«¥ý¥ÍÀ»Ë¥¦³QÅã¥Ü, interleukin-6 ªº¥Í²£³¡¤À¨Ì¾a¥ý¥Í¶Ç¬V¥ý¥Í·Æ¹«»PT. muris ÅãÅSªºÀ»Ë³oºØ·P¨ü¾¹©x¤£¬O¥²nªº¬°±H¥Í¥Íª«ªº¶}°£¦]¬°·Æ¹«¥ý¥ÍÀ»Ë³v¥X±H¥Í¥Íª«¥H°Ê¯à¾Ç©M¨g©ñÃþ«¬°Êª«¤@¼Ë©M¦³¬Û¦üªºcytokine ¦^À³¦b¸zô½¤²O¤Úµ²¡C¦¹¥~, ¾¨ºÞ¦æ°Ê´î¤Öproinflammatory Âà±µ¤èªº²M²G¯Å§O, ¯Ê®u¥ý¥Í¤£¾ÉP¼W¥[ªº¹¹Dª¢¯g¦bT. muris ¶Ç¬V¥H«á·í¥Ñ¥¨¾½²ÓM·J¶°¡BÛÔ¹q¦À¼W¥Í©M¤gµ¢²`«×¦ôp¡C³oÓ¤u§@«ØÄ³, ¾¨ºÞT. muris ¬ù§ôn¯ÀE/S, ¥ý¥Í«n¤£³Q¤¶¤J¦b§K¬Ì¤ÏÀ³ªº¥Í¦¨¹ï³o±H¥Í¥Íª«ªº¡C
PMID: 18624733 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
¤A«¬¨xª¢¯f¬rªí±§Üì«d®zmyeloid ¾ðª¬¹q¦À¥\¯à: ¤A«¬¨xª¢¯f¬r¤@Ó¥i¯àªº§K¬Ì°k©Rµ²ºc¡C
§K¬Ì¾Ç¡C28 6¤ë2008 ¤é;
§@ªÌ: ¾Þ§@¤p«ÇBrouw ¾÷¾¹»y¨¥, Binda RS, van Roosmalen MH, Protzer U, Janssen ¦Ê¤É, van der Molen RG, Woltman ¤W¤È
ºC©Ê¤A«¬¨xª¢¯f¬r(HBV) ¶Ç¬V¬O¤@Ó¤£¥R¤Àªº§K¬Ì¤ÏÀ³ªºµ²ªG©¹¯f¬r¡CMyeloid ¾ðª¬¹q¦À(mDC) ±wªÌ»PºC©ÊHBV ³Q«d®z¦b¥L̪º¦¨¼ô©Ê©M°_§@¥Î, ³y¦¨tolerogenic ¦Ó¤£¬O§ó¥[²£¥Í§K¬Ìªº¦^À³, ¤]³\¹ï¯f¬r«ùÄò®É¶¡°^Äm¡Cµ²ºct³d¥ô¹ï×§ï¹LªºmDC ¥\¯à¨ÌµM¬O¤£©ú¡CHBV ³Q¶Ç¬Vªº±wªÌÅã¥Ü«Ü¦hHBV ·L²É©M¯f¬r³J¥Õ½è¦b¥L̪º´`Àô, ¯S§O¬Oªí±§ÜìHBsAg, ¤¹³\¦h¥æ©¹¦b¯f¬r¡B¨ä¯f¬r³J¥Õ½è©MDC ¤§¶¡¡C¦ôp¬O§_HBV ª½±µ¦a¼vÅTmDC ¥\¯à, HBV ªº§@¥Î©MHBsAg ¦b¤HªºmDC ¦¨¼ô©Ê©M¥\¯à³Q½Õ¬d±o¦b¸ÕºÞ¤º¡C¨Ì·Ó¤w¸g³Q´yz¬°HBV ªºinternalization ¥ÑDC, ¥»¬ã¨sªí¥Ü, °·±d±±¨î¥~³ò¦å²G³Q¬£¥ÍªºmDC ¦³®Ä¦a¨Ã¥B¦û¥hHBsAg ¥H«D©w±`¤è¦¡¡CCytokine ¾ÉPªº¦¨¼ô©Ê¦bHBV ©ÎHBsAg ±«e¨Ì·Ó¥Ñcostimulatory ¤À¤l©M¤@Ó³Q´î¤ÖªºT ¹q¦À¿E°Ê¯à¤Oªº¤@Ó³Q´î¤ÖªººÞ²z³W©w®i¥Ü¨Ì·Ó¥ÑT ¹q¦ÀÂX´²©M¤zÂZ¯À¦÷º¿¥Í²£¦ôp¾ÉPa §ótolerogenic mDC ªí²{«¬, ¡C¥t¥~, HBV ¥X²{·¥¤j´î¤Ö¤Finterleukin-12 ¥Í²£¥ÑmDC ¡C³o¨Çµ²ªGªí¥Ü, ¨âHBV ·L²É©M³Q²b¤ÆªºHBsAg ¦³¤@Ó§K¬Ìmodulatory ¯à¤O, ¤]³\¹ïmDC ªº©x¯à¤£¨}ª½±µ¦a°^Äm¦b±wªÌ»PºC©ÊHBV ¡CHBV ªºª½±µ§K¬ÌºÞ²z§@¥Î©M¬y³qªºHBsAg ·L²É¦bDC ªº¥\¯à¥i¯à³Q¦Ò¼{§@¬°HBV °k²æ§K¬Ìªºµ²ºc¤@³¡¤À¡C
PMID: 18624732 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
CD8(+) ºÞ²zT ¹q¦Àt³d¹ï¹C¿ºIgG °ò¦]½Õ¥Îªº®e®tÂk¯Ç¦bÂIÀY·Æ¹«¡C
§K¬Ì¾Ç¡C20 6¤ë2008 ¤é;
§@ªÌ: Wang R, ÁúG, ºq¦±L, Wang J, ³¯G, ®}R, ¤_M, ¿úJ, ÂnB, §õY
§Ú̪º¦¥ý¬ã¨sÅã¥Ü¥X, lipopolysaccharide (LPS) ³Q¨ë¿Eªºsplenocytes, retrovirally transduced »P¨¦®ò»Ä²æßn°ò65 (¹C¿º) ¨Ã¥B§K¬Ì²y³J¥ÕG (IgG) ¿Ä¦Xºc«Ø, ¥i¯à«OÅ@«DªÎD¿}§¿¯f(ÂIÀY) ·Æ¹«§K¨ü¿}§¿¯f¥Ñ¾ÉP¹C¿º¯S©w®e®t, ¨Ã¥BÁÙ, ¦³CD4(+) ºÞ²zT ¹q¦À(Tregs ªº) ¼W¥[ªº½s¸¹¦b¹C¿ºIgG ³Q¹ï«ÝªºÂIÀY·Æ¹«¡C¦ý¬O, ¤@ÂI¬°¤H©Òª¾Ãö©óCD8(+) Tregs ªº¨¤¦â¹C¿ºIgG °ò¦]½Õ¥Îªº®e®tÂk¯Ç¦bÂIÀY·Æ¹«¡C³o¸Ì, §Ú̵o²{¹C¿ºIgG transduce splenocytes ¾ÉP¦bCD8(+) Foxp3(+) Tregs ªº½s¸¹ªº¤@Ó¼W¶q¦b¸ÕºÞ¤º¡C¨Ï¥ÎT ¹q¦À¨úºÉÀËÅç, §Ú̵o²{, ¤ñ¸ûundepleted ²Õ, ÂIÀY±µ¦¬¤Htransfused »PCD8(-) ©ÎCD8(-) CD25(-) ¹C¿ºIgG transduce splenocytes Åã¥Ü¤F¦bCD8(+) Foxp3(+) T ¹q¦À¡B°ªµo¥Íªº¿}§¿¯f, ÄYµÂªºinsulitis ¡B¹C¿º¯S©whyperresponsiveness ¦b¸ÁºÛ¹q¸Ü©MÅé²G¯Å§O, ©MÅܤƪº¦Ê¤À¤ñªº´î¤Ö¦bcytokine ªí¹F¦¡¤W¡C³o¨Çµ²ªGªí©ú¨ºCD8(+) Tregs, ³Q¹C¿ºIgG transduce splenocytes ¾ÉP¦b¸ÕºÞ¤º, t³dÁÙ¹ï¹C¿ºIgG °ò¦]½Õ¥Îªº®e®tÂk¯Ç¦bÂIÀY·Æ¹«¡C
PMID: 18624731 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
¹q¦ÀÂX´²ÂíÀ£©Mcytokine ªí¹F¦¡¥ÑHL-p36 p36, Haemaphysalis longicornis ºwµªÁn³è²G«Ê¹Ô³Q¬£¥Íªº³J¥Õ½è¡C
§K¬Ì¾Ç¡C20 6¤ë2008 ¤é;
§@ªÌ: Konnai S, Nakajima C, Imamura S, Yamada S, Nishikado H, Kodama M, Onuma M, Ohashi K
¦¥ý, ¤@Ó·Q¹³§í¨î§K¬Ì¤O¤§Ãľ¯½s¨îµ{¦¡°ò¦]³Q¿ë»{¤F±q¤@ӸɥþDNA ¹Ï®ÑÀ]±q³¡¤À³Q÷¾iªºHaemaphysalis longicornis ³è²G«Ê¹Ô³Q¬£¥Í¡C¨Ï¥Î¹ê®Épolymerase Ã즡¤ÏÀ³, °ò¦]³QÅã¥Ü¥Dn¦a³Qªí¹F¦b¦å²G´Á¶¡÷¾i»Pªí¹F¦¡¯¸ÂI¬O¥Dn¦b³è²G«Ê¹Ô; ³o¥ÑWestern §Ëżªº¤ÀªRÃÒ¹ê¤F¡C½Õ¬d³o·s¿oªº³J¥Õ½èªº¥\¯à, ¦b³o¶µ¬ã¨s¤¤, §ÚÌ¥H¤Î´Xcytokines °t¸m¤å¥óªí¹F¦¡¼f¬d¿ð¶wªº³æ®Ö¹q¦À©M¹«¬ìµÊŦ¹q¦Àproliferative ¦^À³¦b³o¨Ç¹q¦À¸Ì¦b¦A²Õ¦X³J¥Õ½è±«e(H. longicornis ¬£¥Í¤F36 000 ¤À¤l¶q³J¥Õ½è: rHL-p36) ¡CrHL-p36 ªº²K¥[¦b´XÓmitogen ³Q¨ë¿Eªº¹q¦Àªº72 ®É¼Æ¯ÑºØ´Á¶¡²M·¡¦a³Q¸T¤îªºÂX´²ªº¶}©l¥Hdose-dependent ¤è¦¡, ¥H¦ñÀH¦a«H¨Ï®Ö¿}®Ö»Ä¯Å§Oªº«¤j¤U¨ÓºÞ²z³W©w¬°interleukin-2 ¡C¸T¤î¦^À³¯à¥Ñ¦Ê¤Ép36 «ÊÂê¼o¤î»P§ÜÅé, «ØÄ³rHL-p36 ªºª½±µ¤¶¤J¦b¹q¦ÀÂX´²¡C¦¹¥~, splenocytes proliferative ¦^À³»PrHL p36 ³Q±µºØªº·Æ¹«³Q¹jµ´ÅãµÛ§C¤ñ¹ï©ó¨º¨Ç±q±±¨î·Æ¹«, «ØÄ³, rHL-p36 ¯àª½±µ¦a¨Ã¥BÀ£¨î§K¬Ì¤ÏÀ³in-vivo ¡C¦³½ìªº¬O, ¹ïsplenocytes ªºmicroarray ¤ÀªRªí¥Ü, ´XÓimmunomodulating °ò¦]ªí¹F¦¡¥ÑrHL-p36 ±µºØ¤U¨Ó½Õ±±¤F¡CÁ`¦Ó¨¥¤§, ³o¨Çµ²ªG«ØÄ³, ¦Ê¤Ép36 ¬O¤]³\¥R·í¦b¥D¾÷§K¬Ì¤ÏÀ³ªº¼Ò¶ô¤Æªº¤@Ó«n¨¤¦âªºimmunosuppressor ¡C
PMID: 18624730 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
¥¨¾½²ÓM¾E²¾¸T¤î¨t¼Æ¨ë¿Einterleukin-17 ªí¹F¦¡©M¥Í²£¦b²O¤Úµ²¹q¦À¸Ì¡C
§K¬Ì¾Ç¡C20 6¤ë2008 ¤é;
§@ªÌ: Stojanović I, Cvjetićanin T, Lazaroski S, Stošić-Grujičić S, Miljković D
Interleukin (IL)-17 ¬O¤@Æg¦¨¿E°Êcytokine ¥Ñ³Ìªñ³Q´yzªºT »²§U¤uÃþ«¬17 (Th17) ¹q¦À¥Í²£, ¦³¦b§K¬Ìªº«n¨¤¦â¹ï²ÓM¥~²Óµß©M´X¦Û°Ê§K¬Ìªº²V¶Ãµo¯fì²z¡CIL-6 ©MÅÜ´«ªº¼Wªø¨t¼Æ(TGF) beta ¬OÃöÁ䪺¬°Th17 ¹q¦Àªº¥Í¦¨¦b·Æ¹«, ·íIL-17 ªº¥Í²£¥Ñ¦UºØ¦U¼Ëªºcytokines, ¥]¬AIL-23, IL-1beta ¡BIL-21 ¡BIL-15 ©M¸~½FÃa¦º¨t¼Æ(TNF) ªüº¸ªk¤ä«ù¦b³o¶µ¬ã¨s¤¤, ¤@¦h¥\¯àcytokine, ¥¨¾½²ÓM¾E²¾¸T¤î¨t¼Æªº¼vÅT(MIF), ¦bIL-17 ¥Í²£¦b·Æ¹«³Q½Õ¬d¤F¡C²O¤Úµ²¹q¦À(LNCs ªº) ³B²z»P¦A²Õ¦XMIF ½Õ±±¤Fmitogen ³Q¨ë¿EªºIL-17 ªí¹F¦¡©M¤Àªcª«¡CÃB¥~, LNCs ±qMIF À»Ë·Æ¹«(mif(-/-)) ÄY«¦a«d®z¤F¥Í²£IL-17, ¨Ã¥BIL-1beta, IL-6, IL-23 ©MTGF beta ¡C·í¨ë¿E»P¦A²Õ¦XIL-1beta ¡BIL-23 ©ÎTNF ªüº¸ªk, mitogen ³QIJµoªºmif(-/-) LNCs ¥R¤À¦a¯à¹F¨ìIL-17 ¥Í²£¬Ý¦b¨g©ñÃþ«¬(«¶q) LNCs, ·íIL-6 ªº²K¥[©MTGF beta ¨S¦³§@¥Î¡C²×©ó, ¦b·Æ¹«ªº®g¤J¥H«á»P§¹¥þFreund ªº»²ÃÄ, IL-17 ªº¤Àªcª«¨Ã¥BIL 17 ¥¿¹q¦Àªº¼Æ¶q¬OÅãµÛ§C¦bmif(±Æªnªº²O¤Úµ²-/-) ·Æ¹«»P«¶q·Æ¹«¤ñ¸û¡CMIF ªº§@¥Î¦bIL-17 ¥Í²£¨Ì¾a©óp38 ¡B²ÓM¥~«H¸¹³Q½Õ±±ªºkinase (ERK), 6¤ëN ²×ºÝkinase (JNK) ¨Ã¥BJanus kinase 2/signal ÅÜ´«¸Ë¸m©M¬¡¤Æp°Æ¥»3 (Jak2/STAT3), ©M¤£¬O®Ö¨t¼Æ(NF)-kappaB ©M®Ö¨t¼Æ³Q¿E¬¡ªºT ¹q¦À(NFAT) µo«H¸¹¡C°O¦íMIF ©MIL-17 ªºÅuú¹ï¿E°Ê©M¦Û°Ê§K¬Ìªº²V¶Ã¯f²z¾Ç, ±qµ²ªG³Q¦s¦b³o¸Ì¥¦¦ü¥G®¶®¶¦³µü, ºË·ÇMIF ¥Íª«¬¡°Ê¯à¬O¤@Ó¦³®ÄªvÀø³~®&¬°³B²zªº³o¼Ë¯e¯f¡C
PMID: 18624729 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
°_°Ê¾ÉPªº²æ®ò°òÅðheterozygous MRL/lpr ·Æ¹«³Q©µ¿ð¦b°ª¿Ë¦X¤OP¯f©Ê§ÜÅ骺¥Í²£©M¦blupus µÇª¢ªºµo®i¡C
§K¬Ì¾Ç¡C20 6¤ë2008 ¤é;
§@ªÌ: ¦¿C, »¯¾÷¾¹»y¨¥, Diaz M
§Ú̦¥ý³ø§i, °_°Ê¾ÉPªº²æ®ò°òÅð(´©§U) heterozygous MRL/lpr ·Æ¹«¦³·¥¤j¦a²M²Ganti-dsDNA ¦Û¨§ÜÅ骺§ó§Cªº¤ô¥¤ñ´©§U¨g©ñÃþ«¬littermates ¡C°²¨Ï´©§Uªº¤wª¾ªº¥\¯à, ³o¸Ì§Ú̼f¬d¬O§_¦bP¯f©Ê¦Û¨§ÜÅ骺³o´î¤Ö¦bheterozygotes ¬O¤@ӯʳ´ªºµ²ªG¦b¿ï¥óÃþ¤Á´«¦Aµ²¦X, Åé¾Àhypermutation, ©Î¨âÓ¡C§Ṳ́Á´«¦Aµ²¦Xªº«¤j·l¶Ë¦V¦h¼Æisotypes ³ø§i°£¤F§K¬Ì²y³J¥ÕG3 (IgG3) ¦b¸ÕºÞ¤º¡C¦ý¬O, IgG ªº²M²G¯Å§O»P´©§U¨g©ñÃþ«¬¯Å§O¬O¬Û¦ü¦b«D±`¥®¤p·Æ¹«¡CÅܤƲÖp¦bB ¹q¦À±qPeyer ªº¸É°vµ{¦¡¨Ã¥BÅãÅS¤F³Q´î¤ÖªºÅé¾Àhypermutation ¦bheterozygotes ¡C¤£¦P©ó¤Á´«¯Ê³´, hypermutation ¯Ê³´¤j·§¾ÉP¤@Ó¬¡Å餺§@¥Î¦]¬°²M²GIgG §ÜÅé±qheterozygotes ¬O¿ô¥Ø§ó§Cªº¿Ë¦X¤O¹ïdsDNA ¤ñ²M²GIgG §ÜÅé±q¨g©ñÃþ«¬littermates ¡C³o«ØÄ³, Åé¾Àhypermutation ¯Ê³´¾ÉP¦Û¨§ÜÅ骺³Q«d®zªº¿Ë¦X¤O¦¨¼ô©Ê¦b³o¨Ç·Æ¹«¨Ã¥B¸ÑÄÀ¯S©wanti-dsDNA §ÜÅ骺§C¤ô¥¦bheterozygotes ¡C³oÃöÁp¤F¥H©µ¿ð¦bµÇŦ·l¶Ëªºµo®i¡C³o¨Çµ²ªG·t¥Ü, ´©§U¯Å§O¼vÅT¿ï¥óÃþ¤Á´«¦Aµ²¦X©MÅé¾Àhypermutation µ²ºc©Mª½±µ¦a²o³s¦Û¨§ÜÅ骺¿Ë¦X¤O¦¨¼ô©Ê¦bautoimmunity ¡C
PMID: 18624728 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
T ¹q¦À¤ô¦À¬Oanergized ¦b¦³¦hµo©Êµw¤Æ¯g¯f¤HÄÀ§K¡C
§K¬Ì¾Ç¡C24 6¤ë2008 ¤é;
§@ªÌ: Fransson §Ú, Liljenfeldt LS, Fagius J, Tötterman TH, Loskog
´_µo¼e®¤ªº¦hµo©Êµw¤Æ¯g(RRMS) ¬O¤¤¥¡¯«¸g¨t²Îªº¤@ºØ½ÆÂø¦Û°Ê§K¬Ìªº¯e¯f¥HÂ\°Êªº¶¥¬q´_µo©M¼e®¤¡CRRMS »{¬°³QT »²§U¤u²Ä¤@Ãþ«¬(Th1) ²O¤Ú²ÓMÅX°Ê¦ý·s«Ø¸ê®Æªí©úTh17 ¦^À³ªº¤¶¤J¡C¦b¥»¬ã¨s¤¤, ¦å¼Ë±q±wªÌ(n = 48) ¨Ã¥B°·±d³æÓ(n = 44) ³Qµû¦ô¤F¬°¥L̪º§K¬Ì¾Çª¬ºA¡CT ¹q¦À±q¦³RRMS ªí¹Fªº°ª¤ô¥¯f¤H°_°Ê¼Ð°OCD28 (P < 0.05) ¨Ã¥B³QÂðΪº¨â¤zÂZ¯À¦÷º¿(CD8: P < 0.05) ©Minterleukin-17 ¦bpolyclonal mitogen ©Îmyelin oligodendrocyte ¿}³J¥Õ§Üì¨ë¿E¡C¦ý¬O, T ¹q¦À±q±wªÌ»PRRMS ÄÀ§K, »P´_µo¹ï¤ñ, ¦³²Ê¦Hªºproliferative ¯à¤O(P < 0.05) «ØÄ³, ¥L̬O¨ü±±©M«O¯d¦bµLÅÜÀ³©Ê¡C³oµLÅÜÀ³©Ê¯à³Q¤¤Â_¥HCD28 «ì´_T ¹q¦À½Æ»sªº¨ë¿E¡C¦¹¥~, ±wªÌ»PRRMS ¦³CD4(+) Foxp3(+) T ºÞ²z¹q¦Àªº¥¿±`¯Å§O¦ýFoxp3(+) ¹q¦ÀÀW²v¯Ê¥FCD127 (interleukin-7 ·P¨ü¾¹©x) ¬O§C¦b±wªÌ»P(¥§¡È12%) ¤k¤h»P°·±d±±¨î(¥§¡È29% ¤ñ¸û) ¡C¦ý¬O, ºÞ²z¹q¦À(CD25(+) ³Q±Æ§Çªº¹q¦À) ±q±wªÌ»PRRMS ¨S¦³Åã¥Ü¦b§íÀ£¯à¤O¤Wªº®tÃB¡CÁ`¦Ó¨¥¤§, ±wªÌ¦brelapse/remission ®i¥Ü¬OTh1 ©MTh17, ·íÄÀ§K, ¬Ý¤W¥h¥Ñtolerogenic µ²ºc±±¨î³Q½Õ¬dªºÅé¥~T ¹q¦À¦^À³¡C
PMID: 18624727 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
³q¦æ¶O¹³·P¨ü¾¹©x4/nuclear ¨t¼ÆkappaB ¸ôªºªÎ¿°»Ä¾ÉPªºÂk¯Ç¦badipocytes »P©T¦³§K¬ÌÃì±µÀç¾iµo«H¸¹¡C
§K¬Ì¾Ç¡C23 6¤ë2008 ¤é;
§@ªÌ: Schaeffler A, Á`P, Buettner R, Bollheimer C, Buechler C, Neumeier M, Kopp A, Schoelmerich J, Falk W
¾Ç²ß¯×ªÕ»Äªº§@¥Î©M¤¶¤J³q¦æ¶O¹³·P¨ü¾¹©x4/nuclear ¨t¼ÆkappaB (TLR-4/NF-kappaB) ¸ô½Í¨ìadipokines ªº¤Àªcª«±qadipocytes 3T3-L1 adipocytes ³Q¨ë¿EÀHµÛ¯×ªÕ»Äªº¼W¥[¾¯¶q¡Cadiponectin ¡Bresistin ©Mmonocyte chemoattractant ³J¥Õ½èªº¤Àªcª«1 (MCP-1) ¥Ñ»Ã¯À³QÃì±µªº§K¬Ì§lªþ¾¯ÀËÅçµû©w¤F¡CNF-kappaB p65 ®Ö¾E²¾©MTLR-4 ªí¹F¦¡¥ÑWestern ¦¾ÂI½Õ¬d¤F¡C§@¥ÎºW±Û¤F¥ÑNF-kappaB ³Q´ú¸Õ¤F¨Ï¥Î¤@ºØ¯S©wNF kappaB §Ü¤Æ¾¯¨Ã¥BTLR 4 ¾ÉPªº§@¥Î³Q¤ÀªR¤F»P¤¤¥ß¤ÆªºTLR-4 §ÜÅé¡C§ô¿£(14)C ¼Ð°O¯×ªÕ»Ä¹ïTLR-4/MD-2 ³Q½Õ¬d¤F¨Ï¥ÎTLR-4 ªº¤@¼Ð»x³Q¼Ð°Oªº²ÓM¥~³¡¥÷³Qº²¤Æ¹ï¥þªøMD-2 ³q¹L³s±µ¾¹(lipopolysaccharide ³]³´¤«) ¡Cadipokines «H¨Ï®Ö¿}®Ö»Ä(mRNA) ªí¹F¦¡¦b¶×²vG¸z¯×ªÕ©Ê²Õ´÷¾i¤F¤@Ӽзǹª«©Î°ª¯×ªÕ¶¼¹¥Ñ¤Ï¦V°Æ¥»polymerase Ã즡¤ÏÀ³½Õ¬d¤F¡CTLR-4 ¾ÉP¦badipocyte ¤À¤Æ´Á¶¡¨Ã¥B¨äªí¹F¦¡³Q´£°ª¸òÀH¯×ªÕ»Ä¨ë¿E¡Cµw¯×©M´ÄÃq»Ä»Äªº¿E°Ê§@¥Î¦bMCP-1 ¤Àªcª«©Mªº´ÄÃqªo»Äªº»Ä¦bresistin ¤Àªcª«³QºW±Û³q¹LNF-kappaB ¡Cµw¯×, ´ÄÃq»Ä©M´ÄÃqªo»Äªº»Äªº¿E°Ê§@¥Î¦bresistin ¤Àªcª«©Mµw¯×»Äªº¿E°Ê§@¥Î¦bMCP-1 ¤Àªcª«³QºW±Û³q¹LTLR-4 ¡CªÎ¿°»ÄºW±Ûªº§@¥Î¥Ñ¤@¤º¦bligand ³y¦¨¦]¬°¯×ªÕ»Ä³QÅã¥Ü¤£§ô¿£ª½±µ¦a¹ïTLR-4/MD-2 ¡C¯×ªÕ©Ê²Õ´mRNA adipokines ªºªí¹F¦¡©M²M²G¯Å§O¨S¦³¤£¦P¦b¶×²v÷¾i¤F°ª¯×ªÕ¶¼¹¡C³oÓ¸ê®Æ´£¨Ñ¯×ªÕ»Ä¥i¯à»P©T¦³§K¬ÌÃì±µÀç¾iªº¤@Ó·s«Ø¤À¤lµ²ºc¡C
PMID: 18624726 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]
¤HªºÂÀ±aªº§K¬Ì½Õ¸`ªº¬¡°Ê¦b¸ÕºÞ¤º¦å²G¬£¥Í¤Fmesenchymal °®²ÓM¡C
§K¬Ì¾Ç¡C24 6¤ë2008 ¤é;
§@ªÌ: Wang M, ·¨Y, ·¨D, ùF, ±çW, ³¢S, ®}J
°©ÀY°©Åè³Q¬£¥Íªºmesenchymal °®²ÓM(BM-MSC) ·í«e³Q½Õ¬d¦bpreclinical ©MÁ{§É³]¸m¥Ñ©ó¥L̪º¦Û·s©Mmultipotent differentiative ¯à¤O©Î¥ĻK¬Ì§í¨îªº¥\¯à¡C¦ý¬O, BM ¤]³\¬O·l¶Ëªº¥Ñ©ó°ª½¯©µ©Ê®½Ãص{¦¡©MBM-MSC decline ¥H¦~ÄÖ¡C©Ò¥H, MSC ±q¨ä¥¦¨Ó·½³Q¬£¥Í³Q¦Ò¼{¤F§@¬°´À¥N¡C¦ý¬O, ¦³°ß¤@¦³ªºª¾ÃѦb¥ĻK¬Ì½Õ¸`ªºÄݩʡC¤HªºÂÀ±a¦å²G(UCB) ¹q¦À¬OBM-MSC ªº¦n´À¥N¶µ¥Ñ©ó·s¥X¥Í¹q¦À¥¼¦¨¼ô¡C¦b³o¶µ¬ã¨s¤¤, §Ú̦¨¥\¹jµ´¤FMSC ±qUCB ¡C³o¨Çclonally ¿±µÈªº¹q¦À§ÎºAªí²{«¬¡B²ÓM¶g´Áª¬ªp¡Bªí±¼Ð°O©M¤À¤Æ¼ç¦b»PBM-MSC ¬O¤@Pªº¡C¦¹¥~, UCB-MSC ³QÂX®i¦b¸ÕºÞ¤º«O¯d§C²£¥Í§K¬Ì©Ê©M¤@Ó§K¬Ì½Õ¸`ªº§@¥Î¡C¬ycytometry ¤ÀªRªí¥Ü, UCB-MSC ¨S¦³ªí¹FCD40, CD40 ligand ¡BCD80 ¡BCD86 ©M±M·~²Õ´¬Û®e©Ê½ÆÂø²ÕII ¤À¤l¡C§ÚÌÅã¥Ü¥X, UCB-MSC ¬O¤£¯à³Ó¥ôªº¾ÉPallogeneic ¥~³ò¦å²G³æ®Ö¹q¦À(PBMC) ÂX´²©M¦³PBMC §K¬Ì¤ÏÀ³ªºdose-dependent ¸T¤î¦b²VÂøªº²O¤Ú²ÓM¦^À³(MLR) ¨Ã¥Bphytohaemagglutinin °_°ÊÀËÅç, ¦b¤zÂZ¯À¦÷º¿³B²z¥H«á¡CÃB¥~, §Ú̵o²{UCB-MSC ¥i¯àÀ£¨î¦¨¼ô¾ðª¬¹q¦Àªº¥\¯à¡C¨Ï¥Îtranswell ¨t²Î, §ÚÌ®i¥Ü¤F¨ú¨M©ó¹q¦ÀÁpµ¸©M¥i·»¸Ñ¨t¼Æªº¸T¤îµ²ºc¡C®Ú¾Ú¬ã¨sµ²ªG§ÚÌ»{¬°, ¶}¤áªºUCB ¯à¦b±N¨Ó¾á·íMSC ªº¼ç¦b¨ä¨Ó·½¬°allogeneic ¥Ó½Ð¡C
PMID: 18624725 [ PubMed - ¨Ì·Ó«öµo¥¬¤H¨ÑÀ³]